Patients who are prescribed higher daily doses of the medication buprenorphine for opioid use disorder are significantly more ...

In a clinical trial, a research team found that administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder (OUD) during pregnancy led to higher rates of ...

Early evidence suggests GLP-1s were linked to lower risks of developing substance use disorders — from alcohol to opioids — and to fewer overdoses and deaths in people with existing addictions.

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

In a clinical trial supported by the National Institutes of Health (NIH), a research team found that administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder ...

Dr. Sarah Spencer sits in the back of the Ninilchik Community Clinic's mobile clinic, assembling an opioid harm-reduction kit. Medications like buprenorphine are important tools in the spectrum of ...

Individuals with opioid use disorder can get “stuck” in particular patterns of brain activity, a new Yale study finds. And this stickiness is more pronounced after they’ve seen images related to ...

Opioid use disorder (OUD) is a serious and complex condition affecting millions of people across the country and contributing to a national public health emergency. Yet stigma and misinformation about ...

Weekly injections led to higher opioid abstinence rate, with good infant outcomes ...

Health insurance loss, changes "may undermine continuity of critical treatment," researche ...

Hospitals in Marion County have been selected to take part in a new, six-month pilot program run by the Oregon Health Authority to improve addiction care in emergency settings. OHA partnered with the ...